Corrections to Effect Size Variances for Continuous Outcomes of Crossover Clinical Trials

Statistics in Medicine - United States
doi 10.1002/sim.7379
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Corrections Regarding Lucinactant and Clinical Trials Involving Lucinactant

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2008English

Sample Size Re-Estimation in Crossover Trials: Application to the AIM HY-INFORM Study

Trials
MedicinePharmacology
2019English

Neurocognitive Outcomes in Neurofibromatosis Clinical Trials

Neurology
Neurology
2016English

Single Momentary Assessments Are Not Reliable Outcomes for Clinical Trials

Contemporary Clinical Trials
MedicinePharmacology
2010English

Sample Size Formula for Joint Modelling of Longitudinal and Time-To-Event Data in Clinical Trials

Trials
MedicinePharmacology
2013English

A Multi-State Model for Designing Clinical Trials for Testing Overall Survival Allowing for Crossover After Progression

Statistics in Biopharmaceutical Research
StatisticsProbabilityPharmaceutical Science
2016English

Practical Handbook of Sample Size Guidelines for Clinical Trials: IBM Compatible Version.

Journal of the American Statistical Association
UncertaintyStatisticsProbability
1993English

Planning and Interpreting the Sample Size of Trials With Multiple Outcomes

Journal of Orthodontics
Orthodontics
2019English

Issues in Outcomes Research: An Overview of Randomization Techniques for Clinical Trials

Journal of Athletic Training
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy